Northern Trust
CRBU icon

Northern Trust’s Caribou Biosciences CRBU Stock Holding History

Northern Trust’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$414K Hold
217,735
– – ﹤0.01% 3690
2025
Q4 		$346K Buy
217,735
+12,663
+6% +$26.6K ﹤0.01% 3784
2025
Q3 		$478K Sell
205,072
-6,916
-3% -$13.1K ﹤0.01% 3658
2025
Q2 		$267K Sell
211,988
-450,055
-68% -$443K ﹤0.01% 3840
2025
Q1 		$605K Sell
662,043
-52,694
-7% -$68.5K ﹤0.01% 3496
2024
Q4 		$1.14M Buy
714,737
+23,531
+3% +$47.3K ﹤0.01% 3337
2024
Q3 		$1.35M Sell
691,206
-18,923
-3% -$38.7K ﹤0.01% 3218
2024
Q2 		$1.16M Sell
710,129
-24,136
-3% -$77.1K ﹤0.01% 3175
2024
Q1 		$3.77M Sell
734,265
-23,097
-3% -$142K ﹤0.01% 2641
2023
Q4 		$4.34M Buy
757,362
+70,197
+10% +$347K ﹤0.01% 2581
2023
Q3 		$3.28M Buy
687,165
+155,181
+29% +$963K ﹤0.01% 2675
2023
Q2 		$2.26M Buy
531,984
+2,979
+0.6% +$13.4K ﹤0.01% 2940
2023
Q1 		$2.81M Sell
529,005
-5,482
-1% -$34.1K ﹤0.01% 2792
2022
Q4 		$3.36M Buy
534,487
+11,329
+2% +$101K ﹤0.01% 2713
2022
Q3 		$5.52M Buy
523,158
+73,078
+16% +$681K ﹤0.01% 2420
2022
Q2 		$2.44M Buy
450,080
+46,310
+11% +$354K ﹤0.01% 2947
2022
Q1 		$3.71M Buy
403,770
+219,683
+119% +$2.31M ﹤0.01% 2757
2021
Q4 		$2.78M Buy
184,087
+11,086
+6% +$216K ﹤0.01% 3052
2021
Q3 		$4.13M Buy
+173,001
New +$4.23M ﹤0.01% 2855

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Northern Trust's CRBU Position: Q1 2026 in Review

Northern Trust held its Caribou Biosciences (CRBU) position steady in Q1 2026 at 217,735 shares worth $414K. The position accounts for ﹤0.01% of the portfolio, ranked #3690.

Northern Trust first reported a position in CRBU in Q3 2021 and has held it in 19 quarters since. The position peaked at $5.52M in Q3 2022. 137 funds tracked by Wall St. Rank hold CRBU as of Q1 2026.

  • Northern Trust held 217,735 shares of Caribou Biosciences worth $414K as of Q1 2026.
  • Northern Trust left its Caribou Biosciences share count unchanged in Q1 2026.
  • Caribou Biosciences made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #3690 holding.
  • Northern Trust first reported a position in Caribou Biosciences in Q3 2021 and has held it in 19 quarters since.
  • Northern Trust's Caribou Biosciences position peaked at $5.52M in Q3 2022.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.